{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:40:05Z","timestamp":1751431205220,"version":"3.41.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint construction project of Henan Provincial Medical Science and Technology Research Program","award":["LHGJ20220093"],"award-info":[{"award-number":["LHGJ20220093"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06423-w","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:09:22Z","timestamp":1751429362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reliability, validity, and acceptability of the simplified Mandarin Chinese EORTC QLQ-OPT30 for uveal melanoma patients"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6316-0111","authenticated-orcid":false,"given":"Yonghui","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panpan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongfang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"4","key":"6423_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/archopht.117.4.461","volume":"117","author":"KJ Cruickshanks","year":"1999","unstructured":"Cruickshanks, K. J. et al. Treatment choice and quality of life in patients with choroidal melanoma. Archives Ophthalmol. (Chicago Ill. : 1960). 117 (4), 461\u2013467 (1999).","journal-title":"Archives Ophthalmol. (Chicago Ill. : 1960)"},{"key":"6423_CR2","unstructured":"Bray, F. et al. Cancer incidence in five continents Vol. XI. International Agency for Research on Cancer. (2022). Available at: https:\/\/ci5.iarc.fr\/Default.aspx. Accessed 18.08.24."},{"issue":"12","key":"6423_CR3","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","volume":"114","author":"G Virgili","year":"2007","unstructured":"Virgili, G. et al. Incidence of uveal melanoma in Europe. Ophthalmology 114 (12), 2309\u20132315 (2007).","journal-title":"Ophthalmology"},{"issue":"9","key":"6423_CR4","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","volume":"118","author":"AD Singh","year":"2011","unstructured":"Singh, A. D., Turell, M. E. & Topham, A. K. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 118 (9), 1881\u20131885 (2011).","journal-title":"Ophthalmology"},{"key":"6423_CR5","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.1111\/j.1755-3768.2020.0180","volume":"99","author":"S Mikhael","year":"2021","unstructured":"Mikhael, S., Tadrosse, A., Yassa, A., Mikhael, M. & Eloy, J. Epidemiological analysis of choroidal melanoma: a population-based analysis, 2000\u20132017. Acta Ophthalmol. 99, S265 (2021).","journal-title":"Acta Ophthalmol."},{"issue":"7","key":"6423_CR6","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1136\/bjophthalmol-2014-305730","volume":"99","author":"X Sheng","year":"2015","unstructured":"Sheng, X. et al. Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patients. Br. J. Ophthalmol. 99 (7), 990\u2013996 (2015).","journal-title":"Br. J. Ophthalmol."},{"key":"6423_CR7","unstructured":"Bray, F. et al. Cancer incidence in five Continents Vol. XI. [online] International Agency for Research on Cancer. (2021). Available at: https:\/\/ci5.iarc.fr\/Default.aspx"},{"issue":"3","key":"6423_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/jnci\/56.3.489","volume":"56","author":"J Scotto","year":"1976","unstructured":"Scotto, J., Fraumeni, J. F., Lee, J. A. & Jr, & Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J. Natl Cancer Inst. 56 (3), 489\u2013491 (1976).","journal-title":"J. Natl Cancer Inst."},{"issue":"3","key":"6423_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000502549","volume":"6","author":"CA Barker","year":"2020","unstructured":"Barker, C. A. et al. Quality of life concerns in patients with uveal melanoma after initial diagnosis. Ocular Oncol. Pathol. 6 (3), 184\u2013195 (2020).","journal-title":"Ocular Oncol. Pathol."},{"issue":"9","key":"6423_CR10","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1136\/bjophthalmol-2018-312915","volume":"103","author":"JE Lu","year":"2019","unstructured":"Lu, J. E. et al. Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007\u20132017. Br. J. Ophthalmol. 103 (9), 1272\u20131277 (2019).","journal-title":"Br. J. Ophthalmol."},{"issue":"22","key":"6423_CR11","first-page":"5684","volume":"13","author":"E Rossi","year":"2021","unstructured":"Rossi, E. et al. Uveal Melanoma Metastasis Cancers, 13(22), 5684. (2021).","journal-title":"Uveal Melanoma Metastasis Cancers"},{"key":"6423_CR12","doi-asserted-by":"publisher","first-page":"175883401875717","DOI":"10.1177\/1758834018757175","volume":"10","author":"J Yang","year":"2018","unstructured":"Yang, J., Manson, D. K., Marr, B. P. & Carvajal, R. D. Treatment of uveal melanoma: where are we now? Therapeutic Adv. Med. Oncol. 10, 1758834018757175 (2018).","journal-title":"Therapeutic Adv. Med. Oncol."},{"issue":"3","key":"6423_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3109\/07357909309024860","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella, D. F. & Tulsky, D. S. Quality of life in cancer: definition, purpose, and method of measurement. Cancer Invest. 11 (3), 327\u2013336 (1993).","journal-title":"Cancer Invest."},{"issue":"2","key":"6423_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.det.2011.11.011","volume":"30","author":"JN Cormier","year":"2012","unstructured":"Cormier, J. N., Cromwell, K. D. & Ross, M. I. Health-related quality of life in patients with melanoma: overview of instruments and outcomes. Dermatol. Clin. 30 (2), 245\u2013viii (2012).","journal-title":"Dermatol. Clin."},{"issue":"2","key":"6423_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000501692","volume":"6","author":"O Scannell","year":"2020","unstructured":"Scannell, O. et al. Quality of life in uveal melanoma patients in ireland: A Single-Centre survey. Ocular Oncol. Pathol. 6 (2), 99\u2013106 (2020).","journal-title":"Ocular Oncol. Pathol."},{"issue":"9","key":"6423_CR16","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/s41433-019-0440-0","volume":"33","author":"L Hope-Stone","year":"2019","unstructured":"Hope-Stone, L., Brown, S. L., Heimann, H. & Damato, B. Comparison between patient-reported outcomes after enucleation and proton beam radiotherapy for uveal melanomas: a 2-year cohort study. Eye (London England). 33 (9), 1478\u20131484 (2019).","journal-title":"Eye (London England)"},{"key":"6423_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ajo.2018.03.015","volume":"193","author":"B Damato","year":"2018","unstructured":"Damato, B. et al. Patient-reported outcomes and quality of life after treatment of choroidal melanoma: A comparison of enucleation versus radiotherapy in 1596 patients. Am. J. Ophthalmol. 193, 230\u2013251 (2018).","journal-title":"Am. J. Ophthalmol."},{"issue":"6","key":"6423_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1159\/000496927","volume":"5","author":"B Damato","year":"2019","unstructured":"Damato, B. et al. Patient-Reported outcomes and quality of life after treatment for choroidal melanoma. Ocular Oncol. Pathol. 5 (6), 402\u2013411 (2019).","journal-title":"Ocular Oncol. Pathol."},{"issue":"1","key":"6423_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10865-021-00252-8","volume":"45","author":"SL Brown","year":"2022","unstructured":"Brown, S. L. et al. Prediction of all-cause mortality from 24 month trajectories in patient-reported psychological, clinical and quality of life outcomes in uveal melanoma patients. J. Behav. Med. 45 (1), 115\u2013123 (2022).","journal-title":"J. Behav. Med."},{"issue":"4","key":"6423_CR20","doi-asserted-by":"publisher","first-page":"e421","DOI":"10.1111\/aos.13655","volume":"96","author":"S Frenkel","year":"2018","unstructured":"Frenkel, S. et al. Long-term uveal melanoma survivors: measuring their quality of life. Acta Ophthalmol. 96 (4), e421\u2013e426 (2018).","journal-title":"Acta Ophthalmol."},{"issue":"1","key":"6423_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13014-021-01902-6","volume":"16","author":"J Gollrad","year":"2021","unstructured":"Gollrad, J. et al. Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma. Radiation Oncol. (London England). 16 (1), 174 (2021).","journal-title":"Radiation Oncol. (London England)"},{"issue":"11","key":"6423_CR22","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/pon.3813","volume":"24","author":"L Hope-Stone","year":"2015","unstructured":"Hope-Stone, L., Brown, S. L., Heimann, H., Damato, B. & Salmon, P. How do patients with uveal melanoma experience and manage uncertainty? A qualitative study. Psycho-oncology 24 (11), 1485\u20131491 (2015).","journal-title":"Psycho-oncology"},{"issue":"5","key":"6423_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00417-015-3216-7","volume":"254","author":"A Klingenstein","year":"2016","unstructured":"Klingenstein, A. et al. Quality of life in the follow-up of uveal melanoma patients after enucleation in comparison to cyberknife treatment. Graefe\u2019s Archive Clin. Experimental Ophthalmol. = Albrecht Von Graefes Archiv fur Klinische Und Experimentelle Ophthalmologie. 254 (5), 1005\u20131012 (2016).","journal-title":"Graefe\u2019s Archive Clin. Experimental Ophthalmol. = Albrecht Von Graefes Archiv fur Klinische Und Experimentelle Ophthalmologie"},{"issue":"5","key":"6423_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson, N. K. et al. The European organization for research and treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl Cancer Inst. 85 (5), 365\u2013376 (1993).","journal-title":"J. Natl Cancer Inst."},{"issue":"3","key":"6423_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/sj.eye.6700639","volume":"18","author":"Y Brandberg","year":"2004","unstructured":"Brandberg, Y. et al. The EORTC ophthalmic oncology quality of life questionnaire module (EORTC QLQ-OPT30). Development and pre-testing (Phase I-III). Eye (London England). 18 (3), 283\u2013289 (2004).","journal-title":"Eye (London England)"},{"issue":"1","key":"6423_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12955-023-02219-6","volume":"22","author":"Y Huang","year":"2024","unstructured":"Huang, Y. & Guo, Y. Quality of life among people with eye cancer: a systematic review from 2012 to 2022. Health Qual. Life Outcomes. 22 (1), 3 (2024).","journal-title":"Health Qual. Life Outcomes"},{"issue":"1","key":"6423_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/ecc.12001","volume":"22","author":"K Chmielowska","year":"2013","unstructured":"Chmielowska, K., Tomaszewski, K. A., Pogrzebielski, A., Brandberg, Y. & Romanowska-Dixon, B. Translation and validation of the Polish version of the EORTC QLQ-OPT30 module for the assessment of health-related quality of life in patients with uveal melanoma. Eur. J. Cancer Care. 22 (1), 88\u201396 (2013).","journal-title":"Eur. J. Cancer Care"},{"issue":"2","key":"6423_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1023\/A:1008981520920","volume":"9","author":"H Zhao","year":"2000","unstructured":"Zhao, H. & Kanda, K. Translation and validation of the standard Chinese version of the EORTC QLQ-C30. Qual. Life Research: Int. J. Qual. Life Aspects Treat. Care Rehabilitation. 9 (2), 129\u2013137 (2000).","journal-title":"Qual. Life Research: Int. J. Qual. Life Aspects Treat. Care Rehabilitation"},{"key":"6423_CR29","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.nepr.2013.04.001","volume":"13","author":"D Polit","year":"2013","unstructured":"Polit, D., Beck, C. & Wilkins, L. W. Nursing research generating and assessing evidence for nursing practice. Nurse Educ. Pract. 13, e29 (2013).","journal-title":"Nurse Educ. Pract."},{"key":"6423_CR30","unstructured":"Devellis, R. F. Scale Development: Theory and Applications (University of Chicago Press, 1991)."},{"key":"6423_CR31","unstructured":"Fayers, P. M. et al. The EORTC QLQ-C30 Scoring Manual 3rd edn (European Organisation for Research and Treatment of Cancer, 2001)."},{"key":"6423_CR32","doi-asserted-by":"crossref","unstructured":"Fayers, P. & Machin, D. Quality of Life: the Assessment Analysis and Inter Pretation of Patient Reported Outcomes (Wiley, 2007).","DOI":"10.1002\/9780470024522"},{"issue":"2","key":"6423_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1207\/s15327752jpa6102_5","volume":"61","author":"DP McAdams","year":"1993","unstructured":"McAdams, D. P. & Zeldow, P. B. Construct validity and content analysis. J. Pers. Assess. 61 (2), 243\u2013245 (1993).","journal-title":"J. Pers. Assess."},{"issue":"2","key":"6423_CR34","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.sapharm.2018.03.066","volume":"15","author":"E Almanasreh","year":"2019","unstructured":"Almanasreh, E., Moles, R. & Chen, T. F. Evaluation of methods used for estimating content validity. Res. Social Administrative Pharmacy: RSAP. 15 (2), 214\u2013221 (2019).","journal-title":"Res. Social Administrative Pharmacy: RSAP"},{"issue":"2","key":"6423_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/1094428114555994","volume":"18","author":"E Cho","year":"2015","unstructured":"Cho, E. & Kim, S. Cronbach\u2019s coefficient alpha: well known but poorly understood. Organizational Res. Methods. 18 (2), 207\u2013230 (2015).","journal-title":"Organizational Res. Methods"},{"issue":"2","key":"6423_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1547-5069.2007.00161.x","volume":"39","author":"HA DeVon","year":"2007","unstructured":"DeVon, H. A. et al. A psychometric toolbox for testing validity and reliability. J. Nurs. Scholarsh. 39 (2), 155\u2013164 (2007).","journal-title":"J. Nurs. Scholarsh."},{"issue":"6","key":"6423_CR37","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/BF00422218","volume":"2","author":"RD Hays","year":"1993","unstructured":"Hays, R. D., Anderson, R. & Revicki, D. Psychometric considerations in evaluating health-related quality of life measures. Qual. Life Research: Int. J. Qual. Life Aspects Treat. Care Rehabilitation. 2 (6), 441\u2013449 (1993).","journal-title":"Qual. Life Research: Int. J. Qual. Life Aspects Treat. Care Rehabilitation"},{"key":"6423_CR38","unstructured":"Tabachnik, B. J. & Fidell, L. S. Using Multivariate Statistics (Harper & Row, 1993)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06423-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06423-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06423-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:09:25Z","timestamp":1751429365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06423-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6423"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06423-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Declarations"}},{"value":"This study has obtained ethical approval from the Research Ethics Committee of Henan Provincial Eye Hospital (registration number HNEEC-2022(54)). The purpose and significance of the study were informed before the interview, and the subjects\u2019 informed consent was obtained. All studies adhered to the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Conception, design, and supervision of the study: YH and PC; data analysis and interpretation: GD and TF; article drafting: YH and PC; article critical revision: DQ; all authors read and approved the final manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions statement"}}],"article-number":"23242"}}